Interim Analysis of Docetaxel, Oxaliplatin and 5-Fluorouracil Combination Chemotherapy in Patients with Advanced Gastric Cancer
의약학 > 내과학
( Mi Jin Ryu ) , ( Sung Rok Kim ) , ( Young Jin Yuh ) , ( Byeong Seok Sohn ) , ( Hye Ran Lee ) , ( Seong Yoon Lee )
대한내과학회 추계학술발표논문집 2011년, 제2011권 제1호, 273(총1페이지)
42846696.pdf [무료 PDF 뷰어 다운로드]
  • ※ 본 자료는 참고용 논문으로 수정 및 텍스트 복사가 되지 않습니다.
  • 구매가격
    30원 (구매자료 3% 적립)
    이메일 발송  스크랩 하기
    자료 다운로드  네이버 로그인
    Introduction: The combination chemotherapy of docetaxel, cisplatin and 5-fluorouracil(5-FU) has shown better survival and response rate than 5-FU/Cisplatin, however the toxicity was substantial. The aim of this study is to determine the efficacy and toxicity of docetaxel, oxaliplatin and 5-FU(DOF) combination chemotherapy in patients with advanced gastric cancer. Methods: Seventeen patients with advanced gastric cancer were treated with the following regimen every 21days: docetaxel 60 mg/m2 IV on day1, oxaliplatin 100 mg/m2 IV on day1, and 5-FU 850 mg/m2 continuous infusion on days1-4. Results: Ten(58.8%) patients showed partial response, 5(29.4%) patients showed stable disease. The overall response rate was 58.8%(95% CI: 35.9-78.4%) and the disease control rate was 88.2%(95% CI: 64.4-97.9%). A total of 100 cycles of chemotherapy was administrated and the dose intensity was 92.4% in docetaxel, 90.9% in oxaliplatin, and 96.6% in 5-FU. The median progression free survival was 6.7months(95% CI, 6.2-7.2 months). Grade3/4 neutropenia and thrombocytopenia occurred in 28cycles(28%) and 1cycle(1%). Grade3 stomatitis, diarrhea and neutropathy occurred in 1cycle(1%), 4cycles(4%) and 5cycles(5%), respectively. Conclusions: The combination chemotherapy of docetaxel, oxaliplatin and 5-FU (DOF) is effective for the treatment of advanced gastric cancer and well tolerated. This result support the continuation of the phaseII trial until target recruitment(n=50).
    사업자등록번호 220-87-87785 대표.신현웅 주소.서울시 서초구 방배로10길 18, 402호 대표전화.070-8809-9397
    개인정보책임자.박정아 통신판매업신고번호 제2017-서울서초-1765호 이메일
    copyright (c) 2009 happynlife. steel All reserved.